TP53 and brain neoplasm: Whole-genome sequencing, transcriptomics, ATAC-sequencing, and imaging mass cytometry were used to characterize syngeneic brain tumor stem cell lines derived from Trp53+/−/Nf1+/− C57Bl6 mice.